首页> 外文期刊>Scandinavian journal of clinical and laboratory investigation. >The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1
【24h】

The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1

机译:CA125,CA15-3,CA19-9,CA72-4,AFP,CEA,NSE和CYFRA21-1的参考间隔

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor markers are noninvasive diagnostic tools for cancer. Their abnormal expression often occurs earlier than clinical symptoms or other detection signals. Appropriate reference intervals (RIs) of tumor markers are important for health evaluation, cancer diagnosis, therapy monitoring and prognosis assessment. In this study, we aimed to establish the RIs of cancer antigen 125 (CA125), CA15-3, CA19-9, CA72-4, alpha fetoprotein (AFP), carcino-embryonic antigen (CEA), neuron-specific enolase (NSE) and cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) in apparently healthy Henan population. A total of 1705 apparently healthy participants (21-89 years) were recruited from five representative geographical regions in Henan province. Nonparametric 95th percentile intervals were used to define the RIs of CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. The test results of CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1 can traceable to reference measurement procedures. The age-and gender-specific RIs of the tumor markers were established. We established age-and gender-specific RIs for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. The newly established RIs should be more suitable for Henan population. It will be valuable for clinicians to make a medical diagnosis, therapeutic management decision and other physiological assessment.
机译:肿瘤标志物是癌症的非侵入性诊断工具。它们的异常表达通常比临床症状或其他检测信号更早发生。肿瘤标志物的适当参考间隔(RIS)对于健康评估,癌症诊断,治疗监测和预后评估是重要的。在这项研究中,我们旨在建立癌症抗原125(CA125),Ca15-3,Ca19-9,Ca72-4,α胎儿(AFP),癌胚胎抗原(CEA),神经元特异性烯醇酶(NSE)的ris )和细胞角蛋白19片段抗原21-1(Cyfra21-1)在显然健康的河南人群中。共有1705名显然是健康的参与者(21-89岁)是从河南省五名代表地理区域招募的。非参数95百分位间隔用于定义Ca125,Ca15-3,Ca19-9,Ca72-4,AFP,CEA,NSE和CYFRA21-1的RIS。 Ca125,Ca15-3,Ca19-9,Ca72-4,AFP,CEA,NSE和CYFRA21-1的测试结果可以追溯到参考测量程序。建立了肿瘤标志物的年龄和性别特异性ris。我们建立了CA125,CA15-3,CA19-9,CA72-4,AFP,CEA,NSE和CYFRA21-1的年龄和性别特异性RIS。新建立的RIS应该更适合河南人口。临床医生提供医疗诊断,治疗管理决策和其他生理学评估将是有价值的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号